Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: James Silverman who wrote (52)	2/20/1998 3:37:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 4974

As best I recall, Praecis is a private Cambridge, MA based company. I think they have a French pharm partner on a prostate cancer treatment. Some fourth quarter biotech moves by Soros announced today: The fund bought 1 million shares of Sofamar/Danek Group Inc. (SDG); 3.2 million shares in Pharmacia & Upjohn (PNU) and 762,000 shares in Incyte Pharmaceuticals Inc. (INCY). The fund sold 1.3 million shares of Amgen Inc. (AMGN) I'd never heard of SDG before - apparently they make spinal surgery products and implants. Peter

To: James Silverman who wrote (52)	2/22/1998 10:26:00 PM
From: Vector1	Read Replies (1) \| Respond to of 4974

James, Caliper is more of a lab on a chip than gene on a chip company. They purport to have proprietary technology which allows them to conduct chemical experimentation in microscopic grooves cut into a glass chip. Potentially allows for greater efficiency in the lab as the chip can be handled by robotics. Also potentially saves money by using much smaller amounts of expensive reagents. On a side note, I just found the thread and bookmarked it. Very interesting. V1